Clinical Trials · NCT01250834
LY2189265 and Atorvastatin Interaction Study
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Eli Lilly and Company
- Enrollment
- 27
- Start date
- Dec 2010
- Locations
- 1 site, United Kingdom
- Primary endpoint
- Pharmacokinetics of Atorvastatin: Maximum Plasma Concentration (Cmax)